Overview Fundamentals API Earnings EOD API Sample Code Pricing

Beijing Sun Novo Pharmaceutical Research Co Ltd (688621 SHG) stock market data APIs

¥37.68 -0.1(-0.3%) as of July 26, 2024
Price chart is built with Anychart

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of drugs in China. The company operates external preparation platform that focuses on the research and development of new drugs and generic drugs for skin external preparations; children's clinical data bridging research center; pediatric drug research and development platform; pediatric drug delivery dosage research and development platform; respiratory tract drug delivery and topical preparation platforms; polypeptide and other drug molecular design and development platform; genotoxic impurity detection platform; technology platform for slow and controlled release preparations; drug synthesis platform; and synthesis technology platform. It also offers SMO, clinical quality management, data management and statistical analysis, project management, test center, clinical research center, clinical trials, TMFDocument management, quality control, Medical Writing, medical monitoring, and pharmacovigilance services; and registration-related services for chemical drugs, biological products, and medical device products. In addition, the company operates quantitative pharmacology platform that use technology on pharmacokinetics, pharmacodynamics, body function, disease mechanism and test process, and other information for quantitative research; and mass spectrometry, immunological analysis, cell biology, and molecular biology platforms that provide biological analysis services for large and small molecular drugs, as well as operates as a Contract Research Organization for Professional Peptide Drug Research and Development. Beijing Sun-Novo Pharmaceutical Research Co., Ltd. was founded in 2009 and is based in Beijing, China.

Beijing Sun Novo Pharmaceutical Research Co Ltd Financial Data Overview

37.78
37.68
-
38.28
37.26
37.26-75.4775
4 231 M
20.2032
112 M
952 M
0.0044
0.039
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '688621',
Type: 'Common Stock',
Name: 'Beijing Sun Novo Pharmaceutical Research Co Ltd',
Exchange: 'SHG',
CurrencyCode: 'CNY',
CurrencyName: 'Renminbi',
CurrencySymbol: '¥',
CountryName: 'China',
CountryISO: 'CN',
OpenFigi: NULL,
ISIN: 'CNE100005139',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
}

Beijing Sun Novo Pharmaceutical Research Co Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 952 M
  • EBITDA 240 M
  • Earnings Per Share 1.87
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Beijing Sun Novo Pharmaceutical Research Co Ltd Earnings via APIs

  • Latest Release 2024-02-26
  • EPS/Forecast NaN

Get Beijing Sun Novo Pharmaceutical Research Co Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com